Karen Eves
Impact in
- Infectious Diseases top 5%
- Clostridium difficile and Clostridium perfringens research
- HIV/AIDS drug development and treatment
- Viral gastroenteritis research and epidemiology
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 9
- Clostridium difficile and Clostridium perfringens research 7
- Viral gastroenteritis research and epidemiology 2
-
- Hepatitis B Virus Studies 2
- Microscopic Colitis 2
- Co-authors
- Barbara J. Kuter (6 shared papers)Stephanie O. Klopfer (11 shared papers)Galia Rahav (4 shared papers)Dalya Güriş (4 shared papers)Dale N. Gerding (5 shared papers)Ciarán P. Kelly (4 shared papers)Princy Kumar (3 shared papers)Misoo C. Ellison (2 shared papers)
- Journals
- Clinical Infectious Diseases (3 papers)Open Forum Infectious Diseases (3 papers)The Lancet HIV (3 papers)Gastroenterology (2 papers)The Lancet (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Karen Eves
22 papers receiving 413 citations
Peers
Comparison fields: 5 of 47
- Infectious Diseases 301
- Virology 48
- Epidemiology 242
- Hepatology 40
- Critical Care and Intensive Care Medicine 18
Countries citing papers authored by Karen Eves
This map shows the geographic impact of Karen Eves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Eves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Eves more than expected).
Fields of papers citing papers by Karen Eves
This network shows the impact of papers produced by Karen Eves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Eves. The network helps show where Karen Eves may publish in the future.
Co-authors
The 25 scholars most cited alongside Karen Eves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 156 | |
| 2 | 2005 | 99 | |
| 3 | 2021 | 36 | |
| 4 | 2021 | 18 | |
| 5 | 2006 | 18 | |
| 6 | 2015 | 17 | |
| 7 | 2001 | 17 | |
| 8 | 2007 | 13 | |
| 9 | 2024 | 13 | |
| 10 | 2024 | 12 | |
| 11 | 2020 | 9 | |
| 12 | Islatravir in combination with doravirine maintains HIV-1 viral suppression through 96 weeks | 2020 | 8 |
| 13 | 2019 | 8 | |
| 14 | 2016 | 6 | |
| 15 | Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea. | 2004 | 4 |
| 16 | 2016 | 3 | |
| 17 | 2017 | 3 | |
| 18 | Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu. | 2004 | 3 |
| 19 | 2026 | 2 | |
| 20 | Islatravir safety analysis through week 48 from a phase 2 trial in treatment naive adults with HIV-1 infection | 2020 | 2 |
About Karen Eves
Karen Eves is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Critical Care and Intensive Care Medicine and Virology, having authored 22 papers that have together received 451 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), Clostridium difficile and Clostridium perfringens research (7 papers), Hepatitis Viruses Studies and Epidemiology (3 papers), Hepatitis B Virus Studies (2 papers), HIV Research and Treatment (2 papers), Microscopic Colitis (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Nosocomial Infections in ICU (2 papers). The work is most often cited by research in Infectious Diseases (301 citations), Virology (48 citations), Epidemiology (242 citations), Hepatology (40 citations) and Critical Care and Intensive Care Medicine (18 citations). Karen Eves has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Barbara J. Kuter, Stephanie O. Klopfer, Galia Rahav, Dalya Güriş, Dale N. Gerding, Ciarán P. Kelly, Princy Kumar, Misoo C. Ellison, Erik R. Dubberke and Bruce Yacyshyn. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, The Lancet HIV, Gastroenterology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.